Since it was founded in 2000 in Grenoble, France, PX'Therapeutics (formerly known as Protein'eXpert) has been offering contract-research, development and manufacturing services for recombinant proteins and monoclonal antibodies.
Our services range from protein engineering, optimisation of drug candidates, humanisation of antibodies, to the production and release of GMP batches for clinical studies.
Our company is organised around technological platforms that ensure the use and improvement of state-of-the-art technologies to address specific requests from our customers. We elaborate relevant scientific programmes and work closely with our customers to fully meet their expectations and bring value to their projects.
With a portfolio of more than 240 customers, and 60% of our turnover being generated out of France, we aim to become one of the leading European Contract Development and Manufacturing Organisations.